Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines.
Callum J, Skubas NJ, Bathla A, Keshavarz H, Clark EG, Rochwerg B, Fergusson D, Arbous S, Bauer SR, China L, Fung M, Jug R, Neill M, Paine C, Pavenski K, Shah PS, Robinson S, Shan H, Szczepiorkowski ZM, Thevenot T, Wu B, Stanworth S, Shehata N; International Collaboration for Transfusion Medicine Guidelines Intravenous Albumin Guideline Group.
Chest. 2024 Aug;166(2):321-338. doi: 10.1016/j.chest.2024.02.049. Epub 2024 Mar 4.
Does this patient have a severe upper gastrointestinal bleed?
Srygley FD, Gerardo CJ, Tran T, Fisher DA.
JAMA. 2012 Mar 14;307(10):1072-9. doi: 10.1001/jama.2012.253.
Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial.
Ortuanya KE, Eleje GU, Ezugwu FO, Odugu BU, Ikechebelu JI, Ugwu EO, Eke AC, Awkadigwe FI, Ezenwaeze MN, Ofor IJ, Okafor CC, Okafor CG.
Womens Health (Lond). 2024 Jan-Dec;20:17455057231225311. doi: 10.1177/17455057231225311.
[Eosinopenia in 2018].
Gil H, Bouldoires B, Bailly B, Meaux Ruault N, Humbert S, Magy-Bertrand N.
Rev Med Interne. 2019 Mar;40(3):173-177. doi: 10.1016/j.revmed.2018.11.008. Epub 2018 Nov 27.
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial.
TREATT Trial Investigators.
Lancet Haematol. 2025 Jan;12(1):e14-e22. doi: 10.1016/S2352-3026(24)00317-X. Epub 2024 Dec 3.
Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71.
Patel SM, Giugliano RP, Morrow DA, Parkar S, Shapiro H, Hug B, Kuder JF, Goodrich EL, Chen SA, Goodman SG, Joung B, Kiss RG, Wojakowski W, Weitz JI, Murphy SA, Wiviott SD, Bloomfield D, Sabatine MS, Ruff CT.
J Am Coll Cardiol. 2025 Jun 17;85(23):2288-2298. doi: 10.1016/j.jacc.2025.04.018.
Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial.
Breau RH, Lavallée LT, Cagiannos I, Momoli F, Bryson GL, Kanji S, Morash C, Turgeon AF, Zarychanski R, Houston BL, McIsaac DI, Mallick R, Knoll GA, Kulkarni G, Izawa J, Saad F, Kassouf W, Fradet V, Rendon R, Shayegan B, Fairey A, Drachenberg DE, Fergusson D.
JAMA Surg. 2024 Dec 1;159(12):1355-1363. doi: 10.1001/jamasurg.2024.4183.
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
Yassi N, Zhao H, Churilov L, Wu TY, Ma H, Nguyen HT, Cheung A, Meretoja A, Mai DT, Kleinig T, Jeng JS, Choi PMC, Duc PD, Brown H, Ranta A, Spratt N, Cloud GC, Wang HK, Grimley R, Mahawish K, Cho DY, Shah D, Nguyen TMP, Sharma G, Yogendrakumar V, Yan B, Harrison EL, Devlin M, Cordato D, Martinez-Majander N, Strbian D, Thijs V, Sanders LM, Anderson D, Parsons MW, Campbell BCV, Donnan GA, Davis SM; STOP-MSU Trial Investigators.
Lancet Neurol. 2024 Jun;23(6):577-587. doi: 10.1016/S1474-4422(24)00128-5. Epub 2024 Apr 20.
CALIPER Hematology Reference Standards (I).
Tahmasebi H, Higgins V, Bohn MK, Hall A, Adeli K.
Am J Clin Pathol. 2020 Aug 5;154(3):330-341. doi: 10.1093/ajcp/aqaa059.
Routine application of the nitroblue tetrazolium test in the clinical laboratory.
Gordon AM, Rowan RM, Brown T, Carson HG.
J Clin Pathol. 1973 Jan;26(1):52-6. doi: 10.1136/jcp.26.1.52.
